Greenphire Launches Industry’s First Patient Experience Dataset Transforming Clinical Trial Planning and Providing a View Into the Patient Journey

Greenphire, a leading software innovator specializing in comprehensive solutions for streamlining clinical trials, today announced the launch of their new Patient Experience Dataset.

Greenphire’s Patient Experience Dataset establishes the industry’s first repository of global patient-level insights by phase, therapeutic area, and country, including average stipends (where permitted) and reimbursements by categorical expense, regulatory compliance guidelines, and more. This dataset delivers a comprehensive view into the patient journey, ultimately enabling sponsors and CROs to more accurately understand the burden associated with taking part in a clinical trial. In addition, this will allow industry stakeholders to better forecast and budget, predict and drive enrollment, streamline EC & IRB submissions in alignment with clinical trial agreements, and deliver the best patient experience.

“Greenphire has the industry’s largest patient experience dataset,” shares CEO Jim Murphy. “These data span a diverse set of therapeutic areas, phases, and countries across hundreds of customers and thousands of studies. Our Patient Experience Dataset gives sponsors the opportunity to access trusted data to transform their own study planning and budgeting with immediate access to average stipend and reimbursement costs by both cost category and percentile. Sponsors can even layer in basic assumptions, calculate estimations, and perform scenario analysis by leveraging our dataset in tandem with our budget development and cost benchmarking tool.”

Historically, the rate and method of patient reimbursements in clinical trials has been fairly inconsistent. To create more transparency regarding the drivers for patient compensation, the DIA has recently initiated a Patient Reimbursement Consortium focused on “examining and optimizing participant study reimbursement in clinical trials.” Greenphire was tapped as a Landmark Analysis Sponsor and working group member because of their years of experience and insights related to supporting patients.

From its recent acquisition of Clincierge, to the launch of this transformational data offering, Greenphire will continue its innovation and transformation in 2024 with additional developments that redefine the future of clinical trials. Discover groundbreaking initiatives, cutting-edge technology, and unparalleled service enhancements at Greenphire.com.

About Greenphire

Greenphire is a Thoma Bravo-backed software company specializing in providing comprehensive solutions for streamlining clinical trials. With a focus on optimizing patient and site experiences, Greenphire offers innovative software for travel and logistics support, automated patient and site payment solutions, and trial budgeting software and analytics. Greenphire Means GO.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240618240629/en/

@GreenphireINC establishes industry’s first patient spend dataset with insights into average stipends and reimbursements, travel methods and expenses, regulatory compliance guidelines, and typical reimbursements on specific study types.